V2X (NYSE:VVX – Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 4.450-4.850 for the period, compared to the consensus estimate of 4.740. The company issued revenue guidance of $4.4 billion-$4.5 billion, compared to the consensus revenue estimate of $4.5 billion.
Analyst Ratings Changes
A number of equities research analysts have issued reports on VVX shares. Citigroup assumed coverage on shares of V2X in a report on Tuesday, January 21st. They set a “buy” rating and a $64.00 target price on the stock. BTIG Research initiated coverage on V2X in a research note on Monday, November 25th. They issued a “buy” rating and a $80.00 price objective on the stock. Raymond James lowered their target price on V2X from $65.00 to $60.00 and set an “outperform” rating for the company in a research note on Tuesday. Royal Bank of Canada cut their price target on V2X from $58.00 to $54.00 and set a “sector perform” rating on the stock in a report on Tuesday. Finally, The Goldman Sachs Group started coverage on V2X in a research note on Thursday, December 12th. They issued a “sell” rating and a $54.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $65.38.
Check Out Our Latest Analysis on V2X
V2X Stock Performance
About V2X
V2X, Inc provides critical mission solutions and support services to defense clients worldwide. It offers a suite of integrated solutions across the operations and logistics, aerospace, training, and technology markets to national security, defense, civilian, and international clients. The company was incorporated in 2014 and is headquartered in Mclean, Virginia.
Recommended Stories
- Five stocks we like better than V2X
- How is Compound Interest Calculated?
- Etsy Loses Its Meme Stock Shine – Is It Still a Buy?
- How to Start Investing in Real Estate
- Stanley Druckenmiller Bets Big on Airline Stocks – Should You?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
Receive News & Ratings for V2X Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for V2X and related companies with MarketBeat.com's FREE daily email newsletter.